Αναζήτηση | Scenario.press

σε πρόσθεσε στο Networking

2025-09-01 10:22:09 -

Pegfilgrastim Biosimilar Market, Trends, Covid-19 Impact Analysis, Size And Growth Estimation by Fact MR

As per Fact.MR’s latest industry analysis, the global pegfilgrastim biosimilar market stands at US$ 1.41 billion in 2023. Global demand for pegfilgrastim biosimilars is projected to reach a market valuation of US$ 3.66 billion by 2033-end, increasing at a CAGR of 10% over the next ten years.This substantial growth is driven by the rising incidence of cancer worldwide, increasing adoption...

0 Σχόλια 0 Μοιράστηκε 127 Views